01 1Dipharma Francis Srl
01 1Masung LS Co., Ltd.
01 1Selegiline hydrochloride
01 1Italy
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-08-19
Registration Number : 20210819-209-J-950
Manufacturer Name : Dipharma Francis Srl
Manufacturer Address : Via Bissone 5 20021 Baranzate (MI), Italy
25
PharmaCompass offers a list of Selegiline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Selegiline Hydrochloride manufacturer or Selegiline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Selegiline Hydrochloride manufacturer or Selegiline Hydrochloride supplier.
A Plurimen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Plurimen, including repackagers and relabelers. The FDA regulates Plurimen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Plurimen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Plurimen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Plurimen supplier is an individual or a company that provides Plurimen active pharmaceutical ingredient (API) or Plurimen finished formulations upon request. The Plurimen suppliers may include Plurimen API manufacturers, exporters, distributors and traders.
click here to find a list of Plurimen suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Plurimen Drug Master File in Korea (Plurimen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Plurimen. The MFDS reviews the Plurimen KDMF as part of the drug registration process and uses the information provided in the Plurimen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Plurimen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Plurimen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Plurimen suppliers with KDMF on PharmaCompass.
